Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Kinase Inhibitors. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102633802B details a scalable 3-step route for 2-chloro-7H-pyrrolo[2,3-d]pyrimidine, offering significant cost reduction and simplified purification for API manufacturing.
Patent CN108546266B details a safe, scalable route for 1,4,6,7-tetrahydropyrano[4,3-c]pyrazole-3-carboxylic acid, offering significant cost reduction in API manufacturing.
Patent CN110885329B reveals a cost-effective synthesis of 1,7-naphthyridine derivatives, eliminating palladium catalysts and toxic reagents for scalable pharmaceutical manufacturing.
Patent CN110964011B reveals a novel synthetic route for 8-chloro-1,7-naphthyridine-3-formaldehyde, offering significant cost reduction and supply chain stability for pharmaceutical manufacturing.
Patent CN109912606B reveals a novel metal-free synthesis for pyrimidoindazoles. Discover cost-effective, scalable manufacturing for kinase inhibitor intermediates.
Discover a novel metal-free synthesis for pyrimidoindazole compounds via patent CN109912606B. Offers cost reduction in API manufacturing and scalable production.
Novel metal-free synthesis of pyrimidoindazoles via one-pot cascade. High yields, mild conditions, ideal for API intermediates and kinase inhibitor development.
Novel metal-free synthesis of pyrimidoindazoles via NH4I catalysis. High yields, mild conditions, ideal for API intermediates and kinase inhibitors.
Discover a novel metal-free one-pot synthesis for pyrimidoindazole compounds. This patent offers cost reduction in API manufacturing and reliable supply chain solutions.
Discover how this metal-free synthesis of 3-ethynyl imidazo[1,2-b]pyridazine reduces 8-step routes to 2 steps, cutting costs and eliminating metal residues for BCR-ABL kinase inhibitor manufacturing.